Xenon Pharmaceuticals Stock Options
| XENE Stock | USD 39.50 1.59 3.87% |
Xenon Pharmaceuticals' option chain provides insight into all available option contracts written on Xenon Pharmaceuticals' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Xenon Pharmaceuticals' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Xenon option contract.
In The Money vs. Out of Money Option Contracts on Xenon Pharmaceuticals
Analyzing Xenon Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Xenon Pharmaceuticals regardless of its overall volatility. This is especially true when Xenon Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Xenon Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Xenon Pharmaceuticals' stock while costing only a fraction of its price.
Xenon Pharmaceuticals' latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 53.74 with a put-to-call open interest ratio of 0.19 over 34 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 0, with calls trading at the volume of 10. This yields a 0.0 put-to-call volume ratio. The Xenon Pharmaceuticals option chain provides detailed quote and price information for the current Xenon Pharmaceuticals option contracts. It shows all of Xenon Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
Xenon Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Xenon Pharmaceuticals' lending market. For example, when Xenon Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Xenon Pharmaceuticals, he or she must hedge the risk by shorting Xenon Pharmaceuticals stock over its option's life.
2024-05-17
The chart above shows Xenon Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Xenon Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Xenon Pharmaceuticals' option, there is no secondary market available for investors to trade.
Xenon Pharmaceuticals Maximum Pain Price across 2024-05-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Xenon Pharmaceuticals close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Xenon Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Xenon Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Xenon stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Xenon Pharmaceuticals' stock price goes up or down, the stock options follow.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenon Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Please note that buying 'in-the-money' options on Xenon Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Xenon Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Xenon Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Xenon Stock moves the wrong way.
At present, Xenon Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 1.3 B, whereas Capital Stock is forecasted to decline to about 783.5 M. Xenon Pharmaceuticals In The Money Call Balance
When Xenon Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Xenon Pharmaceuticals stock is said to be in the money. When it comes to buying Xenon Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Xenon Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Xenon Current Options Market Mood
Xenon Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Xenon Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Xenon Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Xenon Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Xenon Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Xenon contract
Base on the Rule 16, the options market is currently suggesting that Xenon Pharmaceuticals will have an average daily up or down price movement of about 3.36% per day over the life of the 2024-05-17 option contract. With Xenon Pharmaceuticals trading at USD 39.5, that is roughly USD 1.33. If you think that the market is fully incorporating Xenon Pharmaceuticals' daily price movement you should consider buying Xenon Pharmaceuticals options at the current volatility level of 53.74%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Xenon |
Purchasing Xenon Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Xenon calls. Remember, the seller must deliver Xenon Pharmaceuticals stock to the call owner when a call is exercised.
Xenon Pharmaceuticals Option Chain
When Xenon Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Xenon Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Xenon Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Xenon. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Xenon. It also shows strike prices and maturity days for a Xenon Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $20.0 | 0.9847 | 0.0026 | 0 | 2024-05-17 | 19.0 - 23.5 | 0.0 | In |
Call | 2024-05-17 CALL at $22.5 | 0.9832 | 0.0033 | 0 | 2024-05-17 | 16.5 - 21.0 | 0.0 | In |
Call | 2024-05-17 CALL at $25.0 | 0.9461 | 0.0076 | 0 | 2024-05-17 | 14.6 - 18.5 | 0.0 | In |
Call | 2024-05-17 CALL at $27.5 | 0.9233 | 0.011 | 0 | 2024-05-17 | 12.4 - 16.0 | 0.0 | In |
Call | 2024-05-17 CALL at $30.0 | 0.8713 | 0.0156 | 0 | 2024-05-17 | 10.9 - 13.5 | 0.0 | In |
Call | 2024-05-17 CALL at $32.5 | 0.8431 | 0.0214 | 0 | 2024-05-17 | 8.0 - 11.5 | 0.0 | In |
Call | 2024-05-17 CALL at $35.0 | 0.7911 | 0.0295 | 0 | 2024-05-17 | 6.0 - 9.0 | 0.0 | In |
Call | 2024-05-17 CALL at $37.5 | 0.7159 | 0.0409 | 0 | 2024-05-17 | 3.7 - 7.0 | 0.0 | In |
Call | 2024-05-17 CALL at $40.0 | 0.6024 | 0.0532 | 4 | 2024-05-17 | 1.7 - 5.3 | 1.8 | In |
Call | 2024-05-17 CALL at $42.5 | 0.4668 | 0.0547 | 7 | 2024-05-17 | 0.6 - 4.1 | 1.0 | Out |
Call | 2024-05-17 CALL at $45.0 | 0.3093 | 0.0562 | 769 | 2024-05-17 | 0.05 - 2.25 | 0.3 | Out |
Call | 2024-05-17 CALL at $47.5 | 0.163 | 0.0444 | 0 | 2024-05-17 | 0.05 - 1.55 | 0.45 | Out |
Call | 2024-05-17 CALL at $50.0 | 0.1796 | 0.0335 | 0 | 2024-05-17 | 0.05 - 1.35 | 0.0 | Out |
Put | 2024-05-17 PUT at $35.0 | -0.1894 | 0.0316 | 4 | 2024-05-17 | 0.05 - 1.95 | 0.52 | Out |
Put | 2024-05-17 PUT at $37.5 | -0.2702 | 0.0446 | 0 | 2024-05-17 | 0.05 - 2.65 | 0.0 | Out |
Put | 2024-05-17 PUT at $40.0 | -0.3871 | 0.0694 | 0 | 2024-05-17 | 0.7 - 2.55 | 0.0 | Out |
Put | 2024-05-17 PUT at $42.5 | -0.551 | 0.0631 | 135 | 2024-05-17 | 1.7 - 4.8 | 3.9 | In |
Put | 2024-05-17 PUT at $45.0 | -0.7044 | 0.0579 | 0 | 2024-05-17 | 3.5 - 6.2 | 0.0 | In |
Put | 2024-05-17 PUT at $47.5 | -0.8235 | 0.0443 | 0 | 2024-05-17 | 5.5 - 8.2 | 0.0 | In |
Put | 2024-05-17 PUT at $50.0 | -0.8307 | 0.0334 | 0 | 2024-05-17 | 8.0 - 10.9 | 0.0 | In |
Put | 2024-05-17 PUT at $52.5 | -0.8642 | 0.0263 | 0 | 2024-05-17 | 10.8 - 12.9 | 0.0 | In |
Put | 2024-05-17 PUT at $55.0 | -0.8603 | 0.0226 | 0 | 2024-05-17 | 13.0 - 15.9 | 0.0 | In |
Put | 2024-05-17 PUT at $60.0 | -0.8975 | 0.0163 | 0 | 2024-05-17 | 17.9 - 20.7 | 0.0 | In |
Put | 2024-05-17 PUT at $65.0 | -0.8945 | 0.0138 | 0 | 2024-05-17 | 22.9 - 25.9 | 0.0 | In |
Xenon Pharmaceuticals Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Xenon Pharmaceuticals Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Xenon Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Xenon Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Xenon Pharmaceuticals Corporate Directors
Xenon Pharmaceuticals corporate directors refer to members of a Xenon Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Xenon Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Xenon Pharmaceuticals' board members must vote for the resolution. The Xenon Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Michael Hayden | Director | Profile | |
| Dawn Svoronos | Director | Profile | |
| Gary Patou | Director | Profile | |
| Richard Scheller | Director | Profile |
Already Invested in Xenon Pharmaceuticals?
The danger of trading Xenon Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Xenon Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Xenon Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Xenon Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Xenon Pharmaceuticals is a strong investment it is important to analyze Xenon Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xenon Pharmaceuticals' future performance. For an informed investment choice regarding Xenon Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenon Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Xenon Stock analysis
When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Xenon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenon Pharmaceuticals. If investors know Xenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.73) | Quarterly Revenue Growth (1.00) | Return On Assets (0.16) | Return On Equity (0.22) |
The market value of Xenon Pharmaceuticals is measured differently than its book value, which is the value of Xenon that is recorded on the company's balance sheet. Investors also form their own opinion of Xenon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Xenon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Xenon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.